Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets and blood vessels.

G V Born

    Journal of Cardiovascular Pharmacology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Adenosine diphosphate (ADP) is crucial for platelet activation in hemostasis and arterial thrombosis. Inhibiting ADP significantly increases bleeding time, highlighting its role in primary clot formation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nisoldipine increases the bioavailability of endothelial NO.

    Naunyn-Schmiedeberg's archives of pharmacology·2001
    Same author

    Effect of reserpine treatment on low-density lipoproteins in arterial wall and internal organs of rats.

    Journal of cardiovascular pharmacology·2000
    Same author

    Effects of reserpine on expression of the LDL receptor in liver and on plasma and tissue lipids, low density lipoprotein and fibrinogen in rabbits in vivo.

    Atherosclerosis·2000
    Same author

    Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel.

    Stroke·1999
    Same author

    [Factors affecting the trans-endothelial accumulation of atherogenic plasma proteins in artery walls].

    Comptes rendus des seances de la Societe de biologie et de ses filiales·1999
    Same author

    Effect of deoxycorticosterone acetate on blood pressure in relation to accumulation of low-density lipoprotein and fibrinogen by aorta and other tissues of normotensive Wistar rats.

    Journal of hypertension·1997
    Same journal

    Imipramine Can Block Human Cardiac H1-Histamine Receptors.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Ivabradine in the Treatment of POTS Before and After COVID-19 Pandemic: A Systematic Review and Meta-Analysis.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Mineralocorticoid receptor antagonists in managing hypertension: a link with diurnal patterns of blood pressure.

    Journal of cardiovascular pharmacology·2026
    Same journal

    The Cardiac Sarcomere: From development of heritable cardiomyopathies to gene and precision therapies.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Efficacy and Safety of Lorundrostat for Uncontrolled and Treatment-resistant Hypertension: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Safety and Efficacy of Lorundrostat in Uncontrolled Hypertension: A Systematic Review and Meta-Analysis.

    Journal of cardiovascular pharmacology·2026
    See all related articles

    Area of Science:

    • Cardiovascular Biology
    • Hemostasis and Thrombosis Research
    • Platelet Physiology

    Background:

    • Platelet adhesion and aggregation are key to hemostasis and arterial thrombosis.
    • Understanding in vivo platelet aggregation triggers is critical.
    • Novel techniques are needed to study platelet function in vivo.

    Purpose of the Study:

    • To investigate the role of adenosine diphosphate (ADP) in platelet activation during primary hemostasis.
    • To quantify ADP release from damaged vessel walls and platelets.
    • To compare the effects of inhibiting ADP and thromboxane A2 on hemostatic platelet aggregation.

    Main Methods:

    • Developed novel techniques for reproducible bleeding time determination in rat and rabbit mesenteric arterioles.
    • Used enzyme systems to remove ADP and assessed changes in bleeding times.

    Related Experiment Videos

  • Measured free adenosine triphosphate (ATP) as an indicator of ADP at injury sites.

    • Main Results:

    • Infusions removing ADP significantly increased bleeding times at arterial injuries.
    • ADP release from damaged vessel walls is rapid, while platelet release is delayed.
    • Inhibiting ADP was more effective in delaying hemostatic platelet aggregation than inhibiting thromboxane A2 production.

    Conclusions:

    • ADP plays a critical role in initiating platelet activation for primary hemostasis.
    • The rapid release of ADP from damaged vessels explains its importance in vivo.
    • The findings help explain the limited efficacy of simple antiplatelet drugs in certain thrombotic events.